Skip to content

To check irritation of the given samples-Patch Test

Single application ,double blinded,single centered,close patch test to evaluate the safety of cosmetic formulation on healthy human.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/08/006135
Enrollment
26
Registered
2015-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 1. 158/244 Leave on cream 2. 209/010 Leave on cream 3. 209/010 Leave on cream 4. 209/010 Leave on cream 5. 209/010 Leave on cream 6. W 20364 Mosquito repellent wipe 7. G 20364 Mo

Sponsors

Godrej Consumer Products Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Volunteer (female and/or male) in generally good health. 2. Volunteer between the ages of 18 and 50 years. 3. Volunteer has not participated in a similar clinical investigation in the past three months. 4. Volunteer willing to give a written informed consent, agrees for audio video consenting procedures and come for regular observation. 5. Volunteer with clear back

Exclusion criteria

Exclusion criteria: 1. Known history or present condition of allergic response to any cosmetic products. 2. Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings. 3. Medications (e.g. steroids or antihistamines), which would compromise the study. 4. Known alcohol or drug abuse. 5. Pregnant or lactating women. 6. Any history of underlying uncontrolled medical illness including diabetes, liver disease or any other serious medical illness 7. Volunteers participating in any other cosmetics or any other clinical trial. 8. Hypersensitivity to any of the tested products. 9. Any other

Design outcomes

Primary

MeasureTime frame
Outcome TimePoints Evaluation of Skin irritation potential (occurrence of Erythema, Oedema) w.r.t. the investigational productsTimepoint: baseline and then 0 hr, 24 hrs, 7 days of patch removal

Secondary

MeasureTime frame
Investigational product to be tested for irritancy testTimepoint: baseline and then 0 hr, 24 hrs, 7 days of patch removal

Countries

India

Contacts

Public ContactDrSudhir Medhekar

Aim Research Services Pvt. Ltd.

dr.medhekar@aimrspl.com9820321430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026